MYELO THERAPEUTICS
Myelo Therapeutics is focused on the development of treatments for a range of medical needs. It offers myelo001, a molecule that is effective on the hematogenesis. Myelo Therapeutics was founded by Till Erdmann in 2013. It is based in Berlin, Germany.
MYELO THERAPEUTICS
Industry:
Health Care Information Technology
Founded:
2013-01-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.myelotherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+4901709126402
Email Addresses:
[email protected]
Total Funding:
17.42 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache IPv6 Apache 2.4 Unix Strato Strato DNS
Similar Organizations
LifeCourse
LifeCourse is develop innovative concepts in the areas of lifestyle, insurance, health and welfare.
Current Employees Featured
Founder
Investors List
European Commission
European Commission investment in Grant - Myelo Therapeutics
IBB Ventures
IBB Ventures investment in Series B - Myelo Therapeutics
IBB Ventures
IBB Ventures investment in Series A - Myelo Therapeutics
Official Site Inspections
http://www.myelotherapeutics.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Myelo Therapeutics"
Myelo Therapeutics GmbH
We develop medical countermeasures and cancer-supportive care therapies to protect the public from lethal radiation attacks and patients from unintended chemo-radiation effects.See details»
Myelo Therapeutics - Crunchbase Company Profile
Organization. Myelo Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Myelo Therapeutics 2025 Company Profile: Valuation, …
Information on acquisition, funding, cap tables, investors, and executives for Myelo Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Myelo Therapeutics GmbH - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Myelo Therapeutics GmbH of Berlin, Berlin. Get the latest business insights from Dun & Bradstreet.See details»
Myelo Therapeutics GmbH - Drug pipelines, Patents, Clinical trials ...
Explore Myelo Therapeutics GmbH with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 2 news, and 4 literature, Drug:Myelo00Y, Myelo00Z ...See details»
Myelo Therapeutics | F6S
Myelo Therapeutics - Myelo Therapeutics develops Myelo001 to prevent Chemotherapy-induced Neutropenia (CIN), the most frequent and most severe side effect of anticancer therapy. The …See details»
Myelo Therapeutics Closes Financing Round and Gains Strong …
Jun 30, 2020 Myelo Therapeutics GmbH, a clinical-stage pharmaceutical company focused on developing therapies for cancer supportive care and medical countermeasures (MCM), …See details»
About - Myelo Therapeutics GmbH
Mission Statement. Our company is dedicated to advancing the health and well-being of individuals affected by radiation exposure, be it through a nuclear strike, accident or during cancer treatment.See details»
Contact & Legal Info — Myelo Therapeutics GmbH
[email protected]. Myelo Therapeutics GmbH is registered at the municipal court Charlottenburg in Berlin/HRB 149553 B VAT-No./USt-ID./Nr.: DE289451747. Laboratory: Otto …See details»
Our Team - Myeloid Therapeutics
Dr. Gunn is a Professor of Medicine and Immunology at Duke University Medical Center. He received his MD from Southwestern Medical School and completed his residency at Parkland …See details»
Myelo Therapeutics - Overview, News & Similar companies
Sep 25, 2018 Myelo Therapeutics contact info: Phone number: +49 3068908696 Website: www.myelotherapeutics.com What does Myelo Therapeutics do? About Myelo Therapeutics: …See details»
Myelo Therapeutics | VentureRadar
Website: http://www.myelotherapeutics.com/ Develops innovative treatments for high unmet medical needs, focusing on small molecules like myelo001 to address ...See details»
Myelo Therapeutics (Myelo Therapeutics GmbH) - Startbase
Official Website: myelotherapeutics.com; On Social Media: Juristische Person: Myelo Therapeutics GmbH Bundesland: Berlin Übersicht Unternehmen Finanzierung Produkt Team …See details»
Research & Innovation — Myelo Therapeutics GmbH
Acute Radiation Syndrome (ARS), also known as radiation toxicity or radiation sickness, is an acute illness that presents after exposure to high levels of radiation, caused by a nuclear …See details»
Our Mission - Myeloid Therapeutics
Over 10 years we help companies reach their financial and branding goals. Engitech is a values-driven technology agency dedicated.See details»
Newsroom - Myelo Therapeutics GmbH
May 11th, 2020: Myelo Therapeutics Awarded NIH-NIAID Contract Valued up to $6 Million for Development of Myelo001 as Treatment for Acute Radiation Syndrome.See details»
Multiple myeloma treatment: Understanding your ... - Mayo Clinic …
1 day ago Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services …See details»
Our Science - Myeloid Therapeutics
Our therapies incorporate advanced cell and gene therapy methods, combining immunology, genetics, cell biology, and protein science to improve the lives of patients in need.See details»
Careers — Myelo Therapeutics GmbH
Working at Myelo. Our young and dynamic team of scientists is based in the heart of Berlin, where we are dedicated to pushing the boundaries of scientific research.See details»
Myeloid Therapeutics - The Leaders in mRNA-based …
Discover our groundbreaking cancer treatments and explore innovative approaches to harnessing myeloid cells for targeted cancer therapies.See details»